Google DeepMind’s AlphaFold 3 could speed up drug discovery for diseases

Google Deepmind has unveiled the third major version of its “AlphaFold” artificial intelligence model, designed to help scientists design drugs and target disease more effectively.

In 2020, the company made a significant advance in molecular biology by using AI to successfully predict the behaviour of microscopic proteins.

With the latest incarnation of AlphaFold, researchers at DeepMind and sister company Isomorphic Labs—both overseen by cofounder Demis Hassabis—have mapped the behaviour for all of life’s molecules, including human DNA.

The interactions of proteins—from enzymes crucial to the human metabolism, to the antibodies that fight infectious diseases—with other molecules is key to drug discovery and development.

DeepMind said the findings, published in research journal Nature on Wednesday, would reduce the time and money needed to develop potentially life-changing treatments.

“With these new capabilities, we can design a molecule that will bind to a specific place on a protein, and we can predict how strongly it will bind,” Hassabis said in a press briefing on Tuesday.

“It’s a critical step if you want to design drugs and compounds that will help with disease.”

The company also announced the release of the “AlphaFold server”, a free online tool that scientists can use to test their hypotheses before running real-world tests.

Since 2021, AlphaFold’s predictions have been freely accessible to non-commercial researchers, as part of a database containing more than 200 million protein structures, and has been cited thousands of times in others’ work.

DeepMind said the new server required less computing knowledge, allowing researchers to run tests with just a few clicks of a button.

John Jumper, a senior research scientist at DeepMind, said: “It’s going to be really important how much easier the AlphaFold server makes it for biologists—who are experts in biology, not computer science—to test larger, more complex cases.”

Dr Nicole Wheeler, an expert in microbiology at the University of Birmingham, said AlphaFold 3 could significantly speed up the drug discovery pipeline, as “physically producing and testing biological designs is a big bottleneck in biotechnology at the moment”.

—Martin Coulter, Reuters

https://www.fastcompany.com/91121234/alphafold-3-google-deepmind-drug-discovery-disease?partner=rss&utm_source=rss&utm_medium=feed&utm_campaign=rss+fastcompany&utm_content=rss

Created 1y | May 8, 2024, 6:30:02 PM


Login to add comment

Other posts in this group

‘Who did this guy become?’ This creator quit his job and lost his TikTok audience

If you’ve built an audience around documenting your 9-to-5 online, what happens after you hand in your notice?

That’s the conundrum facing Connor Hubbard, aka “hubs.life,” a creator who

Jul 18, 2025, 8:50:06 PM | Fast company - tech
Meta-owned WhatsApp could be banned in Russia. Here’s why

WhatsApp should prepare to leave the Russian market, a lawmaker who regulates the IT sector

Jul 18, 2025, 4:20:03 PM | Fast company - tech
The simple pleasures of computing in 1995

This is an edition of Plugged In, a weekly newsletter by Fast Company global technology editor Harry McCracken. You can sign up to receive it each Friday and read all issues

Jul 18, 2025, 1:50:08 PM | Fast company - tech
The AOL hacking tool that invented phishing and inspired a generation

If you were a teenager on America Online back then, there’s a good chance you got the email. Unlike a lot of the files floating around the early

Jul 18, 2025, 1:50:06 PM | Fast company - tech
How AI brain mapping can improve disease detection

Traditional brain scans only show part of the picture. They can’t fully capture how different regions of the brain communicate—an essential factor in detecting neurological diseases early. Dr.

Jul 18, 2025, 11:40:04 AM | Fast company - tech
Internet regulation is entering its hall pass era

Big changes are coming to the web in the days ahead. On July 25, the U.K.’s Online Safe

Jul 18, 2025, 11:40:03 AM | Fast company - tech